Taro Pharmaceutical Industries Ltd (NYSE:TARO)
| 24.29 Delayed Data As of Mar 24 |  +0.21 / +0.87%Today’s Change | 23.75 Today|||52-Week Range 45.62 | -16.36% Year-to-Date |
Latest TARO News | Press Releases
No recent news for Taro Pharmaceutical Industries Ltd.
Today’s Trading
| Previous close | 24.08 |
| Today’s open | 24.02 |
| Day’s range | 24.02 - 24.48 |
| Volume | 9,622 |
| Average volume (3 months) | 13,276 |
| Market cap | $915.2M |
Data as of 4:00pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -78.57% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +2.25% |
| P/E ratio | 14.1 |
| Price/Sales | 2.90 |
| Price/Book | 0.53 |
Financials
| Next reporting date | May 23, 2023 |
| EPS forecast (this quarter) | $0.23 |
| Annual revenue (last year) | $561.3M |
| Annual profit (last year) | $58.3M |
| Net profit margin | 10.38% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Haifa Bay, Haifa |
Forecasts
